Long-acting testosterone undecanoate for parenteral testosterone therapy

Author： Yassin Aksam A   Huebler Doris   Saad Farid  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.6, 2006-11, pp. : 709-721

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Failure to Maintain a Suppressed Level of Serum Testosterone during Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients

By Williams Jennifer   Sayles Harlan R   Meza Jane L   Sayre Patrick   Sandkovsky Uriel   Gendelman Howard E   Flexner Charles   Swindells Susan  

Nanomedicine, Vol. 8, Iss. 11, 2013-11 ,pp. : 1807-1813

Future Medicine

Access to resources Recommend Favorite

The safety of postmenopausal testosterone therapy

By Maclaran Kate   Panay Nick  

Women's Health, Vol. 8, Iss. 3, 2012-05 ,pp. : 263-275

Future Medicine

Access to resources Recommend Favorite

Testosterone therapy and cancer risk

By  

BJU INTERNATIONAL, Vol. 115, Iss. 2, 2015-02 ,pp. : 317-321

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Efficacy of Combination Treatment with Injectable Testosterone Undecanoate and Daily Tadalafil for Erectile Dysfunction with Testosterone Deficiency Syndrome

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 4, 2015-04 ,pp. : 966-974

John Wiley & Sons Inc

Access to resources Recommend Favorite